Why evidence-based interventions should be integrated into core institutional strategy.
Despite overwhelming evidence demonstrating its efficacy, harm reduction remains one of the most contested areas of public health policy. Interventions such as syringe services, overdose reversal distribution, and supervised consumption sites have consistently proven to reduce infectious disease transmission, prevent fatal overdoses, and connect marginalized populations with broader healthcare services. Yet, the Global State of Harm Reduction report indicates that these services remain critically underfunded and politically vulnerable worldwide. The resistance to harm reduction is rarely rooted in data; it is a failure of institutional governance. When harm reduction is treated as a fringe or controversial add-on to traditional substance use treatment, it is easily marginalized. To maximize public health outcomes, governments and health systems must reframe harm reduction not as an ideological stance, but as essential public health infrastructure.
Integrating harm reduction requires dismantling the structural and legal barriers that criminalize evidence-based care. It demands a whole-of-government approach where law enforcement, public health agencies, and community organizations operate under aligned, equity-focused directives. By treating harm reduction as a core component of institutional strategy rather than an isolated program, public sector leaders can build resilient systems that save lives and address the complex realities of substance use disorders.